Targeting angiogenesis in melanoma: prospects for the future

Targeting angiogenesis in melanoma: prospects for the future

Item
http://www.wikidata.org/entity/Q35076316
Current and future trials of targeted therapies in cutaneous melanomaClinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertensionA review of novel therapies for melanoma.Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cellsTargeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenograftsA new era in the treatment of melanoma: from biology to clinical practice.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P2860

Targeting angiogenesis in melanoma: prospects for the future

Item
http://www.wikidata.org/entity/Q35076316
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting angiogenesis in melanoma: prospects for the future
@ast
Targeting angiogenesis in melanoma: prospects for the future
@en
type
label
Targeting angiogenesis in melanoma: prospects for the future
@ast
Targeting angiogenesis in melanoma: prospects for the future
@en
prefLabel
Targeting angiogenesis in melanoma: prospects for the future
@ast
Targeting angiogenesis in melanoma: prospects for the future
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Targeting angiogenesis in melanoma: prospects for the future
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932